Artificial Intelligence In Precision Medicine Market to Grow with a CAGR of 9.55% through 2030F
Rising prevalence of chronic diseases and demand for drug
discovery and development are factors driving the Global Artificial
Intelligence in Precision Medicine Market in the forecast period
2026-2030F
According to TechSci Research report, “Artificial Intelligence In Precision
Medicine Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2030F”, the Global Artificial Intelligence In
Precision Medicine Market stood at USD 1.24 billion in 2024 and is anticipated
to grow with a CAGR of 9.55% in the forecast period. The increasing
prevalence of chronic diseases such as cancer, cardiovascular disorders, and
diabetes has highlighted the need for more effective treatment strategies.
Precision medicine, which takes into account an individual's genetic makeup,
lifestyle, and environmental factors, offers a targeted approach to disease
management. AI, with its ability to analyze vast datasets and extract
meaningful insights, enhances the precision of treatment recommendations and
drug discovery processes.
Advancements in AI technologies, particularly in the areas
of machine learning and deep learning, have paved the way for more
sophisticated data analysis. Machine learning algorithms can identify patterns
and correlations in patient data, leading to improved diagnostics and treatment
plans. Deep learning, a subset of machine learning, enables AI systems to
perform complex tasks like image recognition and natural language processing,
further aiding in disease diagnosis and prognosis.
The growth of the global artificial intelligence in precision medicine market is closely linked to the accumulation of massive amounts of patient data, including genomic sequences, clinical records, and medical imaging. Genomic sequencing has become more accessible and affordable, allowing researchers and clinicians to understand the genetic basis of diseases. AI algorithms can process this data to identify genetic markers and mutations, facilitating personalized treatment plans and targeted therapies.
One of the primary goals of precision medicine is to move away from the one-size-fits-all approach to healthcare. AI algorithms analyze patient data to identify biomarkers, predict disease progression, and recommend treatment options tailored to an individual's unique genetic and physiological characteristics. This personalized approach not only improves patient outcomes but also minimizes adverse reactions to medications.
The convergence of AI and precision medicine has attracted significant investment from both private and public sectors. Venture capital firms, pharmaceutical companies, and research institutions are channeling funds into AI-driven precision medicine startups. This influx of capital supports research and development efforts, fosters technological innovation, and fuels market growth.
The Global Artificial Intelligence In Precision Medicine Market is segmented
into technology, component, therapeutic application, and company.
Based on therapeutic application, Neurology is the
fastest-growing therapeutic area. This rapid expansion is driven by the
increasing prevalence of neurological disorders such as Alzheimer's and
Parkinson's diseases, which necessitate early and accurate diagnosis. AI
technologies, particularly in imaging and data analysis, enhance the ability to
identify complex neurological conditions, improving patient outcomes.
Advancements in AI facilitate the development of personalized treatment plans,
addressing the unique challenges presented by neurological diseases.
Collaborations between tech companies and healthcare institutions further
accelerate innovation in this field, contributing to the significant growth of
AI applications in neurology within precision medicine.
Based on region, Asia Pacific is the fastest-growing region in the global
Artificial Intelligence in Precision Medicine market due to a combination of
technological advancement, government support, and increasing healthcare
demand. Countries like China, India, Japan, and South Korea are rapidly
adopting AI technologies to modernize healthcare systems and improve diagnostic
accuracy and treatment outcomes. The region’s large and diverse population
contributes to a broad spectrum of medical data, which enhances AI model
training and precision. Governments and private sectors are actively
collaborating on research, infrastructure development, and digital
transformation. There is rising awareness and acceptance of personalized
medicine among healthcare providers and patients. The presence of strong IT
talent and rapidly evolving tech ecosystems further accelerates the development
and integration of AI in healthcare. These factors together position Asia
Pacific as a key growth engine in precision medicine powered by AI.
Major companies operating in Global Artificial Intelligence In Precision
Medicine Market are:
· Glanbia
Plc
· BioXcel
Therapeutics, Inc.
· Sanofi
S.A.
· NVIDIA
Corp.
· Alphabet
Inc. (Google Inc.)
· IBM
Technology corporation
· Microsoft
Corporation
· Intel
Corp.
· AstraZeneca
plc
· GE
HealthCare
· Enlitic,
Inc.
Customers can also request 10% free customization on this
report.
“The Global Artificial Intelligence in Precision Medicine Market is driven by a
convergence of factors that are transforming the healthcare landscape. The
increasing prevalence of chronic diseases, technological advancements in AI,
big data accumulation, personalized treatment approaches, expedited drug
discovery, investment and funding, regulatory support, and collaborations are
all contributing to the rapid growth of this market. As AI continues to
advance, the field of precision medicine will likely witness even more
innovative solutions that revolutionize patient care and outcomes on a global
scale” said Mr. Karan Chechi, Research Director of TechSci Research, a
research-based management consulting firm.
“Artificial Intelligence In Precision Medicine Market, By Technology (Deep Learning, Querying Method, Natural Language Processing, Context-Aware Processing), By Component (Hardware, Software, Service), By Therapeutic Application (Oncology, Cardiology, Neurology, Respiratory, Other), By Region & Competition 2020-2030F”, has evaluated the future growth potential of
Global Artificial Intelligence In Precision Medicine Market and provides
statistics & information on market size, structure and future market growth.
The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Artificial Intelligence In Precision
Medicine Market.
Contact
TechSci Research LLC
420 Lexington Avenue,
Suite 300, New York,
United States- 10170
M: +13322586602
Email: [email protected]
Website: https://www.techsciresearch.com